Literature DB >> 15725235

Serum immunoglobulins in psoriatic erythroderma.

L-F Li1, S A Sujan, H Yang, W-H Wang.   

Abstract

The cause of psoriatic erythroderma (PE) is still unknown. Elevation of serum IgE has been reported in erythroderma, and as serum hyper-IgE is Th2 cell dominated it is of interest to investigate the serum IgE level in PE. In this study, the level of immunoglobulins in the sera of PE patients was analysed by a retrospective case-control study using psoriasis vulgaris (PV) patients as controls. The PE and PV patients were matched in a 1:3 pattern: the first three age and sex matched PV inpatients were selected. All of the subjects were nonatopic and without allergic history. The serum IgE level was found to be elevated in 81.3% of the PE group, which is much higher than that (6.3%) of the controls (odds ratio, 65.0; 95% CI, 11.7-361.2; P < 0.001; chi2 test). The mean level of serum IgE was much higher in the PE group (272.38 +/- 207.63 IU/mL vs. 53.20 +/- 86.05 IU/mL, P < 0.001, Student's t-test). No differences were found for other immunoglobulins. These results suggest that in PE the Th1/Th2 cell imbalance may be switched from Th1 dominant to Th2 dominant. The exact role of serum IgE in PE should be investigated further.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725235     DOI: 10.1111/j.1365-2230.2004.01717.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  14 in total

1.  Analysis of Th1/Th2 response pattern for erythrodermic psoriasis.

Authors:  Ping Zhang; Hong-Xiang Chen; Yi-Qun Duan; Wei-Zhen Wang; Tian-Zhu Zhang; Jia-Wen Li; Ya-Ting Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

2.  Erythrodermic Psoriasis and Staph-Infective Endocarditis-A Conundrum in Succession.

Authors:  Arti Patel; Frederick Venter; Kulraj Grewal; Rupam Sharma; Greti Petersen; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

3.  Two cases of Erythrodermic psoriasis treated with Golimumab.

Authors:  Mayssoun Kudsi; Mhd Amin Alzabibi; Mosa Shibani
Journal:  Ann Med Surg (Lond)       Date:  2022-06-08

4.  Serum levels and expression of IL-25 in patients with psoriatic erythroderma.

Authors:  Kinuko Irie; Toshiyuki Yamamoto
Journal:  Australas J Dermatol       Date:  2022-05-04       Impact factor: 2.481

Review 5.  Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors:  Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

6.  Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Authors:  Yang Lo; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

7.  Analysis of selected allergic reactions among psoriatic patients.

Authors:  Maria Weryńska-Kalemba; Agata Filipowska-Grońska; Michał Kalemba; Anna Krajewska; Alicja Grzanka; Andrzej Bożek; Jerzy Jarząb
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

8.  IgA nephropathy associated with erythrodermic psoriasis: A case report.

Authors:  Li Zhang; Shuai Xue; JinYu Yu; HeNan Si; Ying Xu; Jia Li; FuZhe Ma; ZhongGao Xu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

9.  The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90.

Authors:  Chenhui Wang; Ling Wu; Katarzyna Bulek; Bradley N Martin; Jarod A Zepp; Zizhen Kang; Caini Liu; Tomasz Herjan; Saurav Misra; Julie A Carman; Ji Gao; Ashok Dongre; Shujie Han; Kevin D Bunting; Jennifer S Ko; Hui Xiao; Vijay K Kuchroo; Wenjun Ouyang; Xiaoxia Li
Journal:  Nat Immunol       Date:  2012-12-02       Impact factor: 25.606

10.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.